RHP

Ryman Hospitality Properties

$110.99

+1.98%
May 20, 2026
Bobby Quantitative Model
Ryman Hospitality Properties is a specialized real estate investment trust (REIT) focused on upscale convention center resorts and country music entertainment experiences, operating within the REIT - Hotel & Motel industry. The company is a distinct niche player, owning and operating meetings-focused resorts managed by Marriott under the Gaylord Hotels and JW Marriott brands, and it uniquely integrates hospitality with entertainment assets like the Opry Entertainment Group. The current investor narrative centers on the stock's recovery trajectory within the cyclical hospitality sector, with attention likely focused on the resilience of group and convention travel demand, the performance of its entertainment segment, and its ability to manage a high debt load in a potentially moderating economic environment.

People also watch

Host Hotels & Resorts

Host Hotels & Resorts

HST

Analysis
Apple Hospitality REIT, Inc.

Apple Hospitality REIT, Inc.

APLE

Analysis
Park Hotels & Resorts

Park Hotels & Resorts

PK

Analysis
Pebblebrook Hotel Trust

Pebblebrook Hotel Trust

PEB

Analysis
Welltower

Welltower

WELL

Analysis

BobbyInvestment Opinion: Should I buy RHP Today?

Recommendation: Hold. The core thesis is that RHP presents a high-risk, high-potential-reward proposition where the anticipated earnings recovery is already partially priced in, but severe balance sheet risks warrant caution and limit near-term upside.

Supporting this view, the stock trades at a forward P/E of 21.8x based on expected EPS of $5.96, which prices in significant growth. Profitability metrics are strong (ROE 32.45%, Net Margin 9.45%), and the technical trend is positive. However, these are counterbalanced by extreme leverage (D/E 5.72), an uncovered dividend (payout 117%), and a valuation (P/B 7.8) that offers little margin of safety. The minimal analyst coverage adds an element of uncertainty regarding forward estimates.

The thesis would upgrade to a Buy if the company demonstrates sustained progress in debt reduction while hitting its EPS targets, thereby compressing the forward P/E towards 18x. It would downgrade to a Sell if quarterly earnings meaningfully disappoint against the $5.96 forecast, if the dividend is cut, or if the debt-to-equity ratio increases further. Relative to its own risk profile and the lack of a clear historical valuation benchmark, the stock appears fairly valued to slightly overvalued, demanding perfect execution to justify the current price.

Sign up to view all

RHP 12-Month Price Forecast

The outlook for RHP is bifurcated: its operational recovery story is credible given the high ROE and specific EPS forecasts, but it is hamstrung by a dangerous balance sheet and a fully-valued stock. The base case is a choppy, range-bound performance as the company attempts to grow into its valuation while managing leverage. The stance is neutral due to the offsetting forces; the high debt load caps upside enthusiasm, while the earnings potential provides a floor. Confidence is medium due to the limited analyst coverage, which reduces visibility. The stance would upgrade to bullish on clear evidence of debt reduction and sustained EPS above $6.00, or downgrade to bearish on a dividend cut or a breakdown below $90 support.

Historical Price
Current Price $110.99
Average Target $106.25
High Target $125
Low Target $83.82

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Ryman Hospitality Properties's 12-month outlook, with a consensus price target around $144.29 and implied upside of +30.0% versus the current price.

Average Target

$144.29

2 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

2

covering this stock

Price Range

$89 - $144

Analyst target range

Buy
0 (0%)
Hold
1 (50%)
Sell
1 (50%)

Analyst coverage for Ryman Hospitality Properties is extremely limited, with only two analysts providing estimates, indicating insufficient coverage for a robust consensus view. This minimal coverage typically characterizes smaller or more niche companies and can lead to higher volatility and less efficient price discovery due to a lack of institutional scrutiny and diverse opinions. The provided data includes revenue and EPS estimates but lacks a consensus price target, Buy/Hold/Sell ratings, or a target price range, which prevents any calculation of implied upside or downside or an assessment of analyst sentiment bias. The high estimate for EPS is $6.03 and the low is $5.86, representing a very tight range that suggests high conviction in the near-term earnings outlook among the few covering analysts, though the extremely similar revenue estimates (varying by just $6) further indicate a lack of debate on the fundamental top-line trajectory.

Drowning in data?

Find the real signal!

Bulls vs Bears: RHP Investment Factors

The investment debate for RHP is a classic tension between strong operational recovery potential and a precarious financial structure. The bull case is anchored on the forecasted surge in earnings (forward EPS $5.96), high ROE (32.45%), and a clear technical uptrend. The bear case is dominated by an alarming debt load (D/E of 5.72), an unsustainable dividend, and valuation metrics that appear stretched relative to near-term fundamentals. Currently, the bear points carry stronger evidence due to the concrete, high-magnitude risks embedded in the balance sheet and payout policy. The single most important tension is whether the projected earnings growth materializes quickly and robustly enough to de-lever the balance sheet and cover the dividend, thereby validating the current valuation. If growth disappoints, the high leverage and uncovered dividend could trigger a severe re-rating.

Bullish

  • Strong Earnings Growth Forecast: Analysts project a forward EPS of $5.96, a massive increase from the trailing EPS of $0.04. This implies the market expects a significant recovery in profitability, supported by the lower forward P/E of 21.76x compared to the trailing 24.03x.
  • Exceptional Return on Equity: The company generates a high ROE of 32.45%, indicating efficient use of shareholder equity. This strong profitability metric is a key attraction for investors, especially within a capital-intensive REIT structure.
  • Robust Technical Uptrend: The stock is in a sustained uptrend, with a 6-month gain of 10.74% and trading at 81% of its 52-week range. Recent momentum has accelerated, with the price breaking above $100 and approaching the 52-week high of $112.50, signaling strong buying pressure.
  • Ample Short-Term Liquidity: A current ratio of 73.13 indicates substantial liquidity to meet short-term obligations. This provides a buffer against operational volatility and supports the company's ability to maintain its dividend, despite the high payout ratio.

Bearish

  • Extremely High Financial Leverage: A debt-to-equity ratio of 5.72 signifies a highly leveraged balance sheet. This exposes the company to significant refinancing risk and interest rate sensitivity, potentially pressuring cash flow in a higher-for-longer rate environment.
  • Unsustainable Dividend Payout: The dividend payout ratio of 117.32% exceeds earnings, indicating the distribution is not covered by current profits. This reliance on other cash sources is a red flag for income sustainability and suggests a potential cut if earnings do not recover as forecast.
  • Valuation Lacks Clear Growth Justification: A trailing P/E of 24x and a negative PEG ratio of -1.82 suggest the market is not pricing in strong long-term growth relative to current earnings. The stock trades at a premium P/B of 7.8, which may be difficult to sustain if ROE normalizes.
  • Persistent Market Underperformance: The stock shows negative relative strength versus the SPY over 1-month (-1.89) and 3-month (-4.17) periods, and a significant -18.39 over 1 year. This indicates the rally is isolated and the stock is failing to capture broader market gains, a sign of weak sector sentiment.

RHP Technical Analysis

The stock is in a sustained uptrend, evidenced by a positive 1-year price change of 6.80% and a 6-month gain of 10.74%. With a current price of $104.79, it is trading approximately 81% of the way up its 52-week range ($83.82 to $112.50), indicating strong momentum but also proximity to a key resistance level that could signal potential overextension if tested. Recent short-term momentum shows acceleration, with a 1-month gain of 3.71% and a 3-month gain of 4.25%, though this positive momentum has notably underperformed the broader market, as indicated by relative strength figures of -1.89 (1-month) and -4.17 (3-month) versus the SPY. This divergence suggests the stock's rally may be company or sector-specific rather than driven by broad market tailwinds, warranting caution on the sustainability of the move. Key technical levels are clearly defined by the 52-week high of $112.50 as immediate resistance and the 52-week low of $83.82 as major support; a decisive breakout above $112.50 would signal a new bullish phase, while a breakdown below the recent low near $90 could indicate a trend reversal. The stock's beta of 1.22 confirms it is approximately 22% more volatile than the market, which is significant for risk assessment and implies amplified moves both up and down, particularly relevant given its high debt-to-equity ratio of 5.72.

Beta

1.22

1.22x market volatility

Max Drawdown

-17.8%

Largest decline past year

52-Week Range

$84-$113

Price range past year

Annual Return

+14.4%

Cumulative gain past year

PeriodRHP ReturnS&P 500
1m+6.4%+4.6%
3m+7.7%+8.3%
6m+17.7%+12.5%
1y+14.4%+25.0%
ytd+16.2%+8.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

RHP Fundamental Analysis

Revenue and growth trajectory analysis is constrained as specific quarterly revenue figures and year-over-year growth rates are not available in the provided data. However, analyst estimates point to expected annual revenue of approximately $3.05 billion, suggesting the market is modeling a stable top-line outlook. The company's profitability is confirmed with a positive trailing EPS of $0.04 and a net margin of 9.45%, though the gross margin of 9.93% and operating margin of 18.95% provide a clearer picture of its cost structure and operational efficiency. The payout ratio of 117.32% indicates the current dividend is not fully covered by earnings, which is a point of concern for income-focused investors and suggests a reliance on other cash sources for distributions. Balance sheet health is a critical area of focus, characterized by a very high debt-to-equity ratio of 5.72, which signifies significant financial leverage and risk, especially in a rising interest rate environment. Conversely, the company demonstrates strong returns with an ROE of 32.45% and an ROA of 5.47%, indicating efficient use of both equity and assets to generate profits, and an exceptionally high current ratio of 73.13 suggests ample short-term liquidity, though this figure may be distorted by the REIT structure and specific asset classifications.

Quarterly Revenue

N/A

N/A

Revenue YoY Growth

N/A

YoY Comparison

Gross Margin

N/A

Latest Quarter

Free Cash Flow

N/A

Last 12 Months

Open an Account, get $2 TSLA now!

Valuation Analysis: Is RHP Overvalued?

Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 24.03x and a forward PE of 21.76x; the lower forward multiple implies the market anticipates earnings growth, with the forward estimate of $5.96 per share representing a substantial increase from the trailing period. A peer comparison is limited as specific industry average multiples are not provided in the data, but the trailing PE of 24.03x can be contextualized by the negative PEG ratio of -1.82, which, while often unreliable, suggests the market may not be pricing in significant long-term growth expectations relative to the current earnings multiple. Historical context for the valuation is unavailable due to missing historical ratios data, preventing an assessment of whether the current PE is near the top or bottom of its own historical range; this lack of historical benchmark limits the ability to judge if the stock is priced for optimistic expectations or presents a value opportunity based on its own trading history.

PE

24.0x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

12.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are pronounced, primarily stemming from an extreme debt-to-equity ratio of 5.72, which magnifies both upside and downside. The dividend payout ratio of 117.32% is a direct threat to income investors, as it is not supported by current earnings and may require funding from debt or asset sales. Furthermore, the company's niche focus on group and convention travel makes it highly sensitive to corporate spending cycles and economic downturns, introducing significant earnings volatility that the high fixed-cost structure may amplify.

Market & Competitive Risks include valuation compression, as the stock trades at a premium P/B of 7.8 and a forward P/E of 21.8x without a clear growth narrative (negative PEG). Its beta of 1.22 confirms it is 22% more volatile than the market, amplifying downside during sector-wide selloffs. The persistent negative relative strength versus the SPY indicates the stock is out of favor with the broader market, suggesting it could be vulnerable to sector rotation away from cyclical real estate, especially if interest rates remain elevated.

Worst-Case Scenario involves a macroeconomic slowdown that reduces corporate travel and convention bookings, leading to a miss on the critical $5.96 EPS forecast. This would strain cash flows, jeopardize the already-unsustainable dividend, and make servicing the massive debt burden difficult, potentially triggering credit rating downgrades. In this adverse scenario, the stock could realistically revisit its 52-week low of $83.82, representing a downside of approximately -20% from the current price of $104.79. The historical max drawdown of -17.75% provides a recent benchmark for potential loss magnitude in a stressed environment.

FAQ

The key risks are, in order of severity: 1) Financial Risk: An extremely high debt-to-equity ratio of 5.72 makes the company vulnerable to rising interest rates and refinancing challenges. 2) Dividend Risk: A payout ratio of 117% indicates the dividend is not covered by earnings, raising the risk of a cut. 3) Operational Risk: As a niche convention-focused REIT, revenue is highly sensitive to economic cycles and corporate travel budgets. 4) Market Risk: The stock has consistently underperformed the broader market (negative relative strength) and has a high beta of 1.22, leading to amplified volatility.

The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $100 and $112.50 as it meets EPS estimates of ~$5.96 but struggles with high leverage. The Bull Case (25% probability) targets $112.50 to $125.00 if earnings exceed $6.03 and debt concerns ease. The Bear Case (20% probability) warns of a drop to between $83.82 and $95.00 if earnings disappoint and leverage risks intensify. The most likely outcome is the Base Case, hinging on the critical assumption that the company delivers on its promised earnings recovery without a macroeconomic setback.

RHP appears fairly valued to slightly overvalued based on current data. It trades at a forward P/E of 21.8x, which prices in the anticipated surge in earnings to $5.96 per share. The premium Price-to-Book ratio of 7.8x reflects its high ROE but offers no margin of safety. The negative PEG ratio, while often noisy, suggests the market is not pricing in significant long-term growth beyond the near-term recovery. Compared to its own risk profile—characterized by high leverage and cyclicality—the valuation does not offer a compelling discount. It is valued for near-perfect execution.

RHP is a speculative buy only for investors with a high risk tolerance and a conviction in the group travel recovery narrative. The potential reward is tied to the company hitting its forecasted EPS of $5.96, which could drive the stock higher, but this is counterbalanced by severe risks. The extreme debt-to-equity ratio of 5.72 and an unsustainable dividend payout of 117% create substantial downside potential, estimated at -20% to the 52-week low. For most investors, it is more appropriate as a Hold to monitor execution, rather than a new Buy, unless they are actively seeking high-risk, turnaround situations in the hospitality sector.

RHP is more suitable for a medium- to long-term investment horizon of 2-3 years, allowing time for its earnings recovery thesis to play out and for potential debt reduction efforts to take effect. Its high beta of 1.22 and sensitivity to economic cycles make it a poor candidate for short-term trading, as volatility can be punishing. The uncovered dividend also disqualifies it as a stable long-term income holding. Investors should be prepared to hold through volatility with the goal of capturing the full cycle recovery in group travel, making it appropriate for a tactical, non-core allocation in a diversified portfolio.